Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (41)
  • 2024 (40)
  • 2023 (73)
  • 2022 (54)
  • 2021 (32)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (242)
  • Other (8)

Drug Name

  • Opioids (42)
  • Oxycodone (37)
  • Fentanyl (29)
  • Hydromorphone (13)
  • Synthetic Opioids (10)
  • Benzodiazepines (7)
  • Methamphetamine (7)
  • Morphine (6)
  • Amphetamines (3)
  • Cocaine (3)
  • Heroin (3)
  • Methadone (3)
  • Steroids (3)
  • Marijuana (Cannabis) (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (34)
  • New England (33)
  • New York (23)
  • Seattle (22)
  • Chicago (20)
  • Houston (15)
  • New Jersey (14)
  • Atlanta (13)
  • New Orleans (10)
  • Miami (9)
  • Sede (9)
  • El Paso (7)
  • San Francisco (7)
  • St. Louis (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Los Angeles (4)
  • Omaha (4)
  • Phoenix (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
Clear All Results
PRESS RELEASE

Palomar Hospital Pays $250,000 for Diverting Fentanyl

Junio 03, 2024
SAN DIEGO – Palomar Health, a California public health care district located in San Diego County, has paid $250,000 to resolve allegations of diversion of fentanyl from one of its facilities and failure to keep accurate records for fentanyl. Palomar Health is California’s largest health care district, with campuses in...
Junio 03, 2024
PRESS RELEASE

Former Wallingford Doctor Who Sold Opioid Prescriptions for Cash Sentenced to Federal Prison

Mayo 23, 2024
WALLINGFORD, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that ANATOLY BRAYLOVSKY, 52, of Wallingford, hsa been sentenced by U.S. District Judge Kari A. Dooley in Bridgeport to 90 months of imprisonment, followed by three years of supervised release, for controlled substances and health...
Mayo 23, 2024
PRESS RELEASE

Success For DEA Rocky Mountain Field Division Prescription Drug Take Back Day

Mayo 02, 2024
Thanks to community members, community partners, volunteers and members of the Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) the 26th National Prescription Drug Take Back Day was again a success. This past Saturday, often in challenging weather, people brought in their unneeded, unwanted or expired prescription medications to dozens...
Mayo 02, 2024
PRESS RELEASE

DEA’s National Prescription Drug Take Back Day Enters 15th Year of Removing Unneeded Medications from Communities

Abril 26, 2024
El Paso – Together with its law enforcement partners, the Drug Enforcement Administration will host its 26th National Prescription Drug Take Back Day on Saturday, April 27, from 10 a.m. to 2 p.m. This event aims to remove unneeded prescriptions from homes to help prevent medication misuse by offering anonymous...
Abril 26, 2024
PRESS RELEASE

DEA Rocky Mountain Field Division Encourages Prescription Take Back This Saturday

Abril 25, 2024
The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) is proud to be part of the 26th annual National Prescription Drug Take Back Day this Saturday, April 27, 2024 from 10:00am to 2:00pm MST at dozens of locations across Colorado, Utah, Wyoming and Montana. “DEA’s Take Back events serve as...
Abril 25, 2024
PRESS RELEASE

New Haven Pharmacy and Owner Agree to Pay $120,000 to Settle Controlled Substances Act Allegations

Abril 23, 2024
NEW HAVEN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, today announced that Cornerstone Pharmacy, Inc. (doing business as “Whalley Drug”), and its owner, YONG KWON, have entered into...
Abril 23, 2024
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

Abril 10, 2024
NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
Abril 10, 2024
PRESS RELEASE

Idaho Doctor Pays $96,000 to Settle Allegations That He Wrote Unlawful Prescriptions

Abril 03, 2024
POCATELLO – Dr. Gerald Knouf, a family medicine doctor formerly of Pocatello, Idaho, agreed to pay $96,000 to resolve allegations that he wrote unlawful prescriptions, prescribed dangerous combinations of drugs, and billed Medicare and Medicaid for services that were not performed, U.S. Attorney Josh Hurwit announced today. The settlement also...
Abril 03, 2024
PRESS RELEASE

Owner Of New Jersey Company Admits to Evading U.S. Customs Duties and His Company Agrees to a $3.1 Million Settlement Agreement

Marzo 29, 2024
NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...
Marzo 29, 2024
PRESS RELEASE

Chemical Importer to Pay $300,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

Marzo 25, 2024
WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...
Marzo 25, 2024
Showing 61 - 70 of 250 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Current page 7
  • Página 8
  • Página 9
  • Página 10
  • Página 11
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster